Compare Koninklijke Philips NV (PHG) vs Invesco NASDAQ 100 ETF (QQQM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Koninklijke Philips NV vs Invesco NASDAQ 100 ETF — how do they compare? Koninklijke Philips NV trades at $24.24 (market cap $23.52B), while Invesco NASDAQ 100 ETF trades at $309.39 (market cap $113.40B). The key difference: Invesco NASDAQ 100 ETF is far larger — about 4.8× Koninklijke Philips NV's market cap, and Koninklijke Philips NV pays a 4.17% dividend while Invesco NASDAQ 100 ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Koninklijke Philips NV for 84 Days and Invesco NASDAQ 100 ETF for 54 Days on average.
| PHG | QQQM | |
|---|---|---|
Market Cap | $23.52B | $113.40B |
Volume | 1,635,069 | 2,866,236 |
Sector | Health | Broad Market / Factor |
52-Week High | $32.91 | $312.76 |
52-Week Low | $23.81 | $229.87 |
Typical Hold Time | 84 Days | 54 Days |
Enterprise Value | $29.87B | — |
Dividend Yield | 4.17% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PHG trades at $24.30, up 0.87% with a bearish technical signal despite recent earnings beats. The company shows improving fundamentals with net income turning positive to $895M in 2025 after previous losses, supported by strong cash flow generation. Recent news highlights product innovations including new CT systems and AI healthcare advancements, while institutional ownership shows mixed activity.
The outlook remains cautious with analyst consensus at Hold (63.64%) despite positive earnings momentum. Key risks include cybersecurity threats and competitive pressures in health technology. The stock presents a recovery opportunity but requires monitoring of execution risks and market sentiment shifts.
QQQM trades at $307.85, down 1.33% on the day, with a bullish technical outlook supported by moving averages. The ETF benefits from Nasdaq-100 exposure and a competitive 0.15% expense ratio. Recent institutional buying includes QRG Capital Management increasing its position by 207.5% in Q2 2026. Technical indicators show support at $305 and resistance at $311.
The outlook remains positive given Nasdaq-100 strength and lower fees than QQQ. Risks include market concentration in technology stocks and potential tax implications of distributions. Analyst sentiment favors QQQM for core growth allocations, though some prefer equal-weight alternatives for diversification.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →About Invesco NASDAQ 100 ETF
QQQM is an ETF designed to track the performance of the NASDAQ-100 Index. It provides exposure to the 100 largest non-financial companies listed on the NASDAQ. Positioned as a lower-cost and more long-term-investor-friendly alternative to its peer QQQ, QQQM offers the same fundamental market exposure but typically has a lower share price and is structured to appeal to investors focused on accumulation rather than active trading.
Read more on QQQM →
